XNCR
Xencor, Inc.
NASDAQ · USHealthcareBiotechnology
$18.81+7.67%
Price as of Jul 20, 2026
XNCR capital
Xencor, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.34x
- Net debt / equity
- 0.31x
- Debt / assets
- 0.24x
- Debt / EBITDA
- -1.33x
- Net debt / EBITDA
- -1.22x
Liquidity & coverage
- Current ratio
- 6.57x
- Quick ratio
- 6.57x
- Cash ratio
- 6.06x
- Interest coverage
- -7.59x
- EBITDA / interest
- -4.71x
- Working capital
- $409.4M
Cash & dividend
- FCF / debt
- -1.08x
- Cash flow / debt
- -1.06x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.